Founded in 2009, Immudex is a leading provider of advanced immune monitoring reagents and technologies, helping researchers characterise antigen-specific immune responses with exceptional sensitivity and precision. With a strong focus on translational immunology, Immudex empowers scientists to gain deeper insights into immune function and accelerate the development of next-generation therapeutics.
Best known for its proprietary Dextramer® platform, Immudex offers innovative solutions for the detection, isolation and analysis of antigen-specific T cells, supporting applications in immuno-oncology, infectious disease, vaccine development and cell therapy research. Cambridge Bioscience provides access to Immudex Dextramer® products, supported by local technical expertise and responsive customer service.
Cambridge Bioscience is able to supply the Immuno-oncology portfolio from Immudex in the UK and Ireland.
Your trusted supplier of advanced T-cell monitoring solutions: Immudex
► Industry-leading MHC Dextramer® technology for antigen-specific T-cell detection
► Enhanced sensitivity for detecting low-affinity antigen-specific T cells
► Improved signal-to-noise ratios for reliable flow cytometry analysis
► Supports immuno-oncology, infectious disease, transplantation and autoimmune research
► Suitable for basic, translational and clinical immune monitoring applications
► Trusted by academic, biotech and pharmaceutical researchers worldwide
